B45.0 Pulmonary cryptococcosis

Name of the Condition

• Pulmonary Cryptococcosis

Summary

Pulmonary cryptococcosis is a fungal infection of the lungs caused by the Cryptococcus species, most commonly Cryptococcus neoformans. It is often opportunistic, occurring in individuals with weakened immune systems, and may present with mild to severe respiratory symptoms. The infection can remain localized to the lungs or disseminate to other organs, particularly the central nervous system, depending on the host's immune status.

Causes

The infection results from inhaling Cryptococcus spores, which are typically found in soil contaminated with bird droppings. Once inhaled, the fungus can establish infection in the lungs. In immunocompetent individuals, the infection may be asymptomatic or self-limited, while in immunocompromised hosts, it can progress to severe disease.

Risk Factors

• Weakened immune system, such as from HIV/AIDS, organ transplantation, or immunosuppressive therapy.
• Chronic lung diseases, including emphysema or sarcoidosis.
• Exposure to environments with high concentrations of Cryptococcus spores, such as areas with bird droppings.

Symptoms

• Respiratory symptoms like cough, chest pain, or shortness of breath.
• Fever, night sweats, and weight loss.
• In severe cases, respiratory failure or dissemination to other organs.

Diagnosis

Diagnosis involves identifying Cryptococcus in respiratory samples, such as sputum or bronchoalveolar lavage fluid, through culture, antigen testing, or microscopic examination. Imaging studies like chest X-rays or CT scans may show nodules, masses, or infiltrates. In cases of suspected dissemination, additional testing of cerebrospinal fluid or other sites may be performed.

Treatment Options

Treatment depends on the severity of the infection and the patient's immune status. Mild cases in immunocompetent individuals may not require therapy, while moderate to severe cases or immunocompromised patients typically receive antifungal medications, such as fluconazole or amphotericin B, often followed by maintenance therapy.

Prognosis and Follow-Up

Prognosis varies based on the patient's immune status and the extent of infection. Immunocompetent patients generally have a good prognosis with appropriate treatment, while immunocompromised individuals may experience recurrence or dissemination. Follow-up includes monitoring for symptom resolution and repeat imaging or testing if symptoms persist or worsen.

Complications

• Respiratory failure in severe lung involvement.
• Dissemination to the central nervous system, leading to meningitis or encephalitis.
• Chronic lung disease or scarring in persistent infections.

Lifestyle & Prevention

• Avoid exposure to environments with high concentrations of bird droppings, such as鸽舍 or areas with decaying organic matter.
• For immunocompromised individuals, maintain regular medical care and adhere to prescribed therapies to reduce infection risk.
• Practice good hygiene and avoid activities that may aerosolize contaminated soil.

When to Seek Professional Help

Seek medical attention if you experience persistent respiratory symptoms, such as cough, chest pain, or shortness of breath, especially if you have a weakened immune system. Prompt evaluation is critical if symptoms worsen or if you develop signs of dissemination, such as headache, neck stiffness, or confusion.

Tips for Medical Coders

When coding pulmonary cryptococcosis, use ICD-10-CM code B45.0. Ensure documentation supports the diagnosis, including clinical findings, imaging results, and laboratory confirmation of Cryptococcus in respiratory samples. Differentiate from other fungal lung infections and note any associated conditions, such as immunosuppression, to support accurate coding.